Files
2026-07-06 17:28:03 -04:00

5.6 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability. Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability. us/states/tx Texas Legislature 88 SB 241 Texas SB 241 (88)
bill
DIABETES (S0486)
HEALTH & HUMAN SERVICES COMMISSION (V0177)
Health--Other Diseases & Medical Conditions (I0383)
Insurance--Health & Accident (I0422)
MEDICINE & PRESCRIPTION DRUGS (S7338)
enacted
Perry
Talarico
5 52 4 2022-11-16 2023-05-27 openstates ocd-bill/ffa1eb26-44d6-4464-981a-b5de5e46923f ftp://ftp.legis.state.tx.us/bills/88R/billhistory/senate_bills/SB00200_SB00299/SB 241.xml 00c347621502d15dd41d773d66de5e8dae5c6bb9e6b6d08a2b065529ad656de5 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-tx

Texas SB 241 (88) — Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Introduced (filed) — source
  2. Engrossed (committee substitute) — source
  3. House Committee Report (committee substitute) — source
  4. Senate Committee Report (committee substitute) — source
  5. Enrolled (enrolled) — source

Votes

  • passage — 1391 (pass) · lower
  • passage — 00 (pass) · upper
  • Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSSB 241 be placed on its third reading and final passage. — 310 (pass) · upper
  • passage — 00 (pass) · upper

Sponsors

  • Perry — primary (person)
  • Talarico — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2022-11-16 Received by the Secretary of the Senate filing, introduction
  • 2022-11-16 Filed filing
  • 2023-02-15 Read first time introduction, reading-1
  • 2023-02-15 Referred to Health & Human Services referral-committee
  • 2023-03-08 Scheduled for public hearing on . . .
  • 2023-03-08 No action taken in committee
  • 2023-03-15 Scheduled for public hearing on . . .
  • 2023-03-15 Considered in public hearing
  • 2023-03-15 Testimony taken in committee
  • 2023-03-15 Vote taken in committee
  • 2023-03-20 Reported favorably as substituted committee-passage-favorable
  • 2023-03-20 Recommended for local & uncontested calendar
  • 2023-03-20 Committee report printed and distributed
  • 2023-03-22 Placed on intent calendar
  • 2023-03-23 Rules suspended-Regular order of business
  • 2023-03-23 Read 2nd time reading-2
  • 2023-03-23 Amendment(s) offered amendment-introduction
  • 2023-03-23 Amended amendment-passage
  • 2023-03-23 Vote recorded in Journal
  • 2023-03-23 Passed to engrossment as amended amendment-passage
  • 2023-03-23 Vote recorded in Journal
  • 2023-03-23 Three day rule suspended
  • 2023-03-23 Record vote
  • 2023-03-23 Read 3rd time reading-3
  • 2023-03-23 Passed passage
  • 2023-03-23 Record vote
  • 2023-03-23 Reported engrossed
  • 2023-03-27 Received from the Senate introduction
  • 2023-04-10 Read first time introduction, reading-1
  • 2023-04-10 Referred to Public Health referral-committee
  • 2023-05-03 Considered in formal meeting
  • 2023-05-03 Recommended to be sent to Local & Consent referral-committee
  • 2023-05-03 Reported favorably w/o amendment(s) committee-passage, committee-passage-favorable
  • 2023-05-06 Comte report filed with Committee Coordinator filing
  • 2023-05-07 Committee report distributed
  • 2023-05-08 Comm. report sent to Local & Consent Calendar
  • 2023-05-10 Considered in Local & Consent Calendars
  • 2023-05-12 Placed on Local, Consent, and Res. Calendar
  • 2023-05-12 Read 2nd time reading-2
  • 2023-05-12 Passed to 3rd reading
  • 2023-05-12 Nonrecord vote recorded in Journal
  • 2023-05-12 Read 3rd time reading-3
  • 2023-05-12 Passed passage
  • 2023-05-12 Record vote
  • 2023-05-12 Nonrecord vote recorded in Journal
  • 2023-05-15 House passage reported passage
  • 2023-05-15 Reported enrolled enrolled
  • 2023-05-16 Signed in the Senate passage
  • 2023-05-16 Signed in the House passage
  • 2023-05-16 Sent to the Governor executive-receipt
  • 2023-05-27 Signed by the Governor executive-signature
  • 2023-05-27 Effective on . . . . . . . . . . . . . . . became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ffa1eb26-44d6-4464-981a-b5de5e46923f. Confidence: reported (aggregated from official Texas legislature records).